Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in arthrogenous inhibition

A Young1

  • 1University Department of Geriatric Medicine, Royal Free Hospital School of Medicine, London, United Kingdom.

Annals of the Rheumatic Diseases
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Beliefs About Medicines In An Urban Black Hypertension Population.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.

Thrombosis research·2016
Same author

Editorial (Thematic Issue: Neuroprotective Effects of Li - It is Elementary).

Current Alzheimer research·2016
Same author

A bacterial-biofilm-induced oral osteolytic infection can be successfully treated by immuno-targeting an extracellular nucleoid-associated protein.

Molecular oral microbiology·2016
Same author

Pneumonia Caused by Klebsiella spp. in 46 Horses.

Journal of veterinary internal medicine·2015

Muscle weakness after joint disease, known as arthrogenous inhibition, stems from nerve signal disruption. New techniques study this inhibition, with electrical stimulation showing therapeutic potential.

Area of Science:

  • Neuroscience
  • Physiology
  • Rehabilitation Medicine

Background:

  • Joint disease frequently causes significant muscle weakness, even without pain.
  • This weakness is attributed to arthrogenous inhibition, a disruption of motoneurone signaling from the affected joint.
  • Arthrogenous inhibition is understudied despite its impact on muscle function.

Purpose of the Study:

  • To explore the phenomenon of arthrogenous inhibition in joint disease.
  • To review current experimental techniques for studying arthrogenous inhibition in humans.
  • To discuss potential neurophysiological mechanisms and therapeutic strategies.

Main Methods:

  • Review of existing scientific literature on arthrogenous inhibition.
  • Discussion of experimental techniques applicable to human studies.

Related Experiment Videos

  • Analysis of findings from animal studies regarding neurophysiological mechanisms.

    • Main Results:

    • Several experimental techniques now allow for the study of arthrogenous inhibition in humans.
    • Animal studies suggest underlying neurophysiological mechanisms for this inhibition.
    • Temporary reduction of arthrogenous inhibition is possible by silencing afferent signals, but practical application is limited.

    Conclusions:

    • Arthrogenous inhibition is a key factor in muscle weakness associated with joint disease.
    • Further research is needed to understand selective muscle fiber atrophy and motor unit inhibition.
    • Electrical stimulation presents a potential therapeutic avenue, with effectiveness potentially linked to stimulus parameters.